Agenda
VolitionRx Limited
NYSE AMERICAN: VNRX
Industry: Diagnostics - Cancer
Scott Powell, Head of Investor Relations & U.S. Chief Financial Officer
Avicanna Inc.
OTCQX: AVCNF | TSX: AVCN
Industry: BioPharma - Cannabinoids
Aras Azadian, Chief Executive Officer, Co-Founder
Alpha Cognition Inc.
OTCQB: ACOGF | TSX-V: ACOG
Industry: Biopharma - neurodegenerative disorders
Michael McFadden, CEO
Willow Biosciences Inc.
OTCQX: CANSF | TSX: WLLW
Industry: BioTech - Cannabinoids
Trevor Peters, President & CEO
Filament Health Corp.
Pink: FLHLF | NEO: FH
Industry: Drug Development - Psychedelics
Ben Lightburn, CEO
Novamind Inc.
OTCQB: NVMDF | CSE: NM
Industry: Mental Health - Psychedelics
Reid Robison, MD, MBA - Chief Medical Officer, Director
Salarius Pharmaceuticals, Inc.
Nasdaq: SLRX
Industry: BioPharma – Oncology
David Arthur, CEO
MedX Health Corp.
TSX-V: MDX
Industry: MedTech – Dermatology
Mike Druhan, President Dermatological Services
Wesana Health Holdings Inc.
OTCQB: WSNAF | CSE: WESA
Industry: Psychedelics
Daniel Carcillo, CEO
Compass Therapeutics, Inc.
OTCQB: CMPX
Industry: BioPharma – Oncology
Thomas Schuetz, CEO
Else Nutrition Holdings Inc.
OTCQX: BABYF | TSX-V: BABY
Industry: Nutrition - Food Science
Hamutal Yitzhak, Co - Founder & CEO